Edoardo Errichiello1, Roberto Giorda2, Antonella Gambale3,4, Achille Iolascon3,4, Orsetta Zuffardi1, Sabrina Giglio5. 1. Unit of Medical Genetics, Department of Molecular Medicine, University of Pavia, Pavia, Italy. 2. Laboratory of Molecular Biology, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy. 3. Department of Molecular Medicine and Medical Biotechnologies, University "Federico II" of Naples, Naples, Italy. 4. CEINGE, Advanced Biotechnologies, Naples, Italy. 5. Unit of Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Abstract
BACKGROUND: Copy number variants in coding and noncoding genomic regions have been implicated as risk factor for schizophrenia (SCZ). Rare duplications of the RB1CC1 gene were found enriched in SCZ patients. Considering that the effect of such duplications on RB1CC1 expression has never been evaluated and partial gene duplications of RB1CC1 have also been reported in SCZ patients, it is unclear whether the pathogenesis is mediated by haploinsufficiency rather than genuine overexpression of the gene. METHODS AND RESULTS: We studied a patient with schizophrenia, suicidality, and obesity, who carried a de novo RB1CC1 complete duplication, as assessed by high-resolution array-CGH. Molecular breakpoint cloning allowed to identify nonhomologous end joining (NHEJ) as driving mechanism in this rearrangement. On the contrary, trio-based whole-exome sequencing excluded other potential causative variants related to the phenotype. Functional assays showed significant overexpression of RB1CC1 in the peripheral blood lymphocytes of the proband compared to control subjects, suggesting overdosage as leading mechanism in SCZ pathophysiology. CONCLUSION: We hypothesized a pathogenetic model that might explain the correlation between RB1CC1 overexpression and schizophrenia by altering different cell signaling pathways, including autophagy, a promising therapeutic target for schizophrenic patients.
BACKGROUND: Copy number variants in coding and noncoding genomic regions have been implicated as risk factor for schizophrenia (SCZ). Rare duplications of the RB1CC1 gene were found enriched in SCZ patients. Considering that the effect of such duplications on RB1CC1 expression has never been evaluated and partial gene duplications of RB1CC1 have also been reported in SCZ patients, it is unclear whether the pathogenesis is mediated by haploinsufficiency rather than genuine overexpression of the gene. METHODS AND RESULTS: We studied a patient with schizophrenia, suicidality, and obesity, who carried a de novo RB1CC1 complete duplication, as assessed by high-resolution array-CGH. Molecular breakpoint cloning allowed to identify nonhomologous end joining (NHEJ) as driving mechanism in this rearrangement. On the contrary, trio-based whole-exome sequencing excluded other potential causative variants related to the phenotype. Functional assays showed significant overexpression of RB1CC1 in the peripheral blood lymphocytes of the proband compared to control subjects, suggesting overdosage as leading mechanism in SCZ pathophysiology. CONCLUSION: We hypothesized a pathogenetic model that might explain the correlation between RB1CC1 overexpression and schizophrenia by altering different cell signaling pathways, including autophagy, a promising therapeutic target for schizophrenicpatients.
Authors: A Piton; J Gauthier; F F Hamdan; R G Lafrenière; Y Yang; E Henrion; S Laurent; A Noreau; P Thibodeau; L Karemera; D Spiegelman; F Kuku; J Duguay; L Destroismaisons; P Jolivet; M Côté; K Lachapelle; O Diallo; A Raymond; C Marineau; N Champagne; L Xiong; C Gaspar; J-B Rivière; J Tarabeux; P Cossette; M-O Krebs; J L Rapoport; A Addington; L E Delisi; L Mottron; R Joober; E Fombonne; P Drapeau; G A Rouleau Journal: Mol Psychiatry Date: 2010-05-18 Impact factor: 15.992
Authors: Jacobine E Buizer-Voskamp; Jan-Willem Muntjewerff; Eric Strengman; Chiara Sabatti; Hreinn Stefansson; Jacob A S Vorstman; Roel A Ophoff Journal: Biol Psychiatry Date: 2011-04-13 Impact factor: 13.382
Authors: Anne S Bassett; Chelsea Lowther; Daniele Merico; Gregory Costain; Eva W C Chow; Therese van Amelsvoort; Donna McDonald-McGinn; Raquel E Gur; Ann Swillen; Marianne Van den Bree; Kieran Murphy; Doron Gothelf; Carrie E Bearden; Stephan Eliez; Wendy Kates; Nicole Philip; Vandana Sashi; Linda Campbell; Jacob Vorstman; Joseph Cubells; Gabriela M Repetto; Tony Simon; Erik Boot; Tracy Heung; Rens Evers; Claudia Vingerhoets; Esther van Duin; Elaine Zackai; Elfi Vergaelen; Koen Devriendt; Joris R Vermeesch; Michael Owen; Clodagh Murphy; Elena Michaelovosky; Leila Kushan; Maude Schneider; Wanda Fremont; Tiffany Busa; Stephen Hooper; Kathryn McCabe; Sasja Duijff; Karin Isaev; Giovanna Pellecchia; John Wei; Matthew J Gazzellone; Stephen W Scherer; Beverly S Emanuel; Tingwei Guo; Bernice E Morrow; Christian R Marshall Journal: Am J Psychiatry Date: 2017-07-28 Impact factor: 18.112
Authors: Elizabeth S Mo; Qianni Cheng; Andrey V Reshetnyak; Joseph Schlessinger; Stefania Nicoli Journal: Proc Natl Acad Sci U S A Date: 2017-10-23 Impact factor: 11.205
Authors: Matthew Halvorsen; Ruth Huh; Nikolay Oskolkov; Jia Wen; Sergiu Netotea; Paola Giusti-Rodriguez; Robert Karlsson; Julien Bryois; Björn Nystedt; Adam Ameur; Anna K Kähler; NaEshia Ancalade; Martilias Farrell; James J Crowley; Yun Li; Patrik K E Magnusson; Ulf Gyllensten; Christina M Hultman; Patrick F Sullivan; Jin P Szatkiewicz Journal: Nat Commun Date: 2020-04-15 Impact factor: 14.919